83 patients with human immunodeficiency virus ( hiv ) infection ( cdc groups ii , iii , or iv-a ) were randomised in a crossover trial of sodium-diethyldithiocarbamate ( ditiocarb sodium , 'imuthiol ' ) ( 10 mg/kg body weight given orally once a week ) against placebo .
C0700086
ditiocarb sodium
C0878291
imuthiol